Search
CareDx Inc
CDNAAdd to Watchlist
77.570USD
-8.290-9.65%
Market hours 11/05, 12:44（ET）
4.08BMarket Cap
LossP/E TTM
CareDx Inc (CDNA) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to CareDx Inc in the past month.
Buy
3 Strong Buy
2 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
86.167USD-1.42%
CDNA Analyst Recommendation Trends
In the current month, CDNA has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. CDNA average Analyst price target in the last month is 86.167.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
3
3
3
3
3
2
2
0
0
0
1
1
1
2
3
4
4
4
4
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
8
7
7
7
8
9
9
CDNA Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, CDNA EPS is projected to reach 0.363 in FY2026Q4, following reported EPS of 0.370 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.13
0.23
0.25
0.36
0.31
Actual
0.05
2.15
0.37
--
--
Surprise
-58.87%
+823.35%
+50.17%
--
--
FAQs
What is CareDx Inc's expected revenue for the next quarter?
CareDx Inc's expected revenue is 132.42M.
What is CareDx Inc's price target?
Analysts forecast that CareDx Inc's price target is USD 86.17, with the highest forecast at USD 100.00 and the lowest forecast at USD 46.00.
How have CareDx IncCDNA's recent earnings per share performed?
The market expectation was USD 0.37, while CareDx IncCDNA's earnings per share (EPS) for the previous quarter was USD 2.15. EPS for the next quarter is expected at USD 0.36.
What is the analyst rating for CareDx Inc?
Based on the ratings of CareDx Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.